Patent details

EP0614984 Title: Anti-TNF alpha human monoclonal antibodies

Basic Information

Publication number:
EP0614984
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP941025603
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Anti-TNF alpha human monoclonal antibodies
French Title of Invention:
Anticorps monoclonaux humains anti-TNF alpha
German Title of Invention:
Humane monoklonale anti-TNF alpha Antikörper
SPC Number:
91661

Dates

Filing date:
21/02/1994
Grant date:
16/08/2001
EP Publication Date:
16/08/2001
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/09/1994
EP B1 Publication Date:
16/08/2001
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/02/2012
Expiration date:
21/02/2014
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/09/2010
 
 

Name:
Bayer HealthCare LLC
Address:
555 White Plains Road, Tarrytown, NY 10591, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
19/01/2010
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Wetzel Gayle D.
Address:
United States (US)

2

Name:
Lembach Kenneth J.
Address:
United States (US)

3

Name:
Boyle Petra
Address:
United States (US)

Priority

1

Priority Number:
26957
Priority Date:
05/03/1993
Priority Country:
United States (US)

2

Priority Number:
145060
Priority Date:
29/10/1993
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/24;
IPC classification:
C12P 21/08;
Filing date Document type Number of pages